BioSpace News Archive

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In this role, Ms. Reiter will drive new business opportunities at Calyxt to support the company’s recently announced go-to-market strategies.

ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced that ALX148 clinical results have been selected for presentation at the SITC 35 th Anniversary Annual Meeting, November 9 –14, 2020. The abstract for our presentation appeared briefly and in error on the SITC website this morning, prior to its intended release on

Updated COVID-19 case projections released by PolicyLab at Children’s Hospital of Philadelphia show parts of the Southeast and Southwest will see infection rates rise significantly over the next four weeks as the early fall wave expands beyond the northern areas of the country to blanket much of the nation.

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced two upcoming poster presentations describing preclinical evaluations of ATRC-101 at the 35 th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020), to be held virtually from Nov

The Public Health Agency of Canada is collaborating with provincial and territorial public health and food safety partners to investigate an outbreak of Vibrio parahaemolyticus infections occurring in four provinces.

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported preliminary financial results for the three months ended September 30, 2020.

Envista Holdings Corporation will report financial results for its third quarter 2020 on Thursday, October 29, 2020.

BioNJ announced the winners of its 2020 Company and Pitch Presentation Competition held in conjunction with the organization’s 10th Annual BioPartnering Conference held virtually last Tuesday, October 6, and Wednesday, October 7.

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that seven abstracts were accepted for presentation at the virtual SITC 2020 Annual Meeting from November 9-14, 2020.